Authors

Beyond the Horizon: A New Era for Faster, Smarter Clinical Trials

Current industry trends align with the need for improved, fit for purpose technology.

How AI and Regulation are Reshaping the Future of Drug Safety

Balancing the emerging benefits of AI in pharmacovigilance with new responsibilities and demands from regulators in enhancing efficiency and safety.

AI-Powered Non-Interventional Research Delivers What DCTs Promised

A unified technology approach improves study efficiency and data collection.

The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials

Emerging applications of AI/ML, automation, and digitization are helping sponsors cut clinical trial start-up times to as little as four weeks, reduce data errors, and enhance patient engagement—demonstrating how tech-enabled processes are reshaping trial efficiency and experience across the study lifecycle.

Leveraging AI/Machine Learning as an End-to-End Differentiator

A well-designed approach can benefit clinical trials from protocol design to site support.

The Transformative Power of Data Analytics in Clinical Trials

Leveraging and benchmarking insights to boost efficiency and optimization.

5 Strategies for Bridging the Sponsor-Site Tech Divide

Results from survey of 100 site personnel suggest a disconnect is present between these stakeholders.

Empowering the Workforce of the Future: The Trends and Training That Will Drive the Future of Drug Development

A new global report finds that clinical research teams are making progress but still lack the skills and tools needed to keep pace with growing trial complexity and emerging technologies.

Applied AI and Advanced Automation in Clinical Trials

Use cases spotlight the growing potential of generative AI in the CRO space.

After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies

Advancing toward more meaningful use of PRO data by making it systematic, transparent, and built into trial design.

Clinical Trial Monitoring: Should Randomization Be Included?

While randomization is required by regulatory bodies, it is up to the sponsor on how to conduct it.

Navigating the Intersection of Accessibility and Measurement Integrity in eCOA

Clinical research evolves to prioritize patient-centered outcomes, integrating accessibility standards in electronic data capture for inclusive clinical trials.

KRI Overload: When More Isn’t Better

To maximize the impact of signal detection, KRI frameworks should follow a few guiding principles.

Tapping the Patient Voice as a Strategic Differentiator

The future of clinical trial design involves incorporating the patient experience into strategic asset planning.

Harnessing Unstructured Data and Hospital Interoperability

The potential of next-generation platforms in transforming patient recruitment.

Realtime Electronic Data Capture at Investigator Sites: Laboratory Data and Beyond

Digital Measures of Health: What’s in it for Patients?

Exploring the different stages in the development of a digital measure, and the activities and steps key to achieving meaningful impact for patients.

Clinical Trials as a Competitive Edge: Strategic Considerations

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.

The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials

Emerging applications of AI/ML, automation, and digitization are helping sponsors cut clinical trial start-up times to as little as four weeks, reduce data errors, and enhance patient engagement—demonstrating how tech-enabled processes are reshaping trial efficiency and experience across the study lifecycle.

When AI Learns to Speak Every Language: An eCOA Migration Study

New data show that applying AI to the migration of translated COAs into eCOA platforms can meaningfully reduce errors, accelerate localization workflows, and support broader global patient participation—while still relying on human reviewers to ensure linguistic precision and clinical integrity.

Evolving Toward Empowerment: How We Are Deepening Relationships With Patients

Multilayered strategies such as working with patient advocacy organizations and leveraging technology can help industry better partner with patients.

Harnessing Technology and Adopting Unified Approaches to Optimize Pharmacovigilance Activities

How digital intake solutions driven by technological advancements can help overcome the challenges of operating across different regulatory markets.

Critical Questions to Ask Your IRB

Find out if you’re working with the right IRB.

Focusing on Site Needs and Challenges: Quick Tips for Sponsors/CROs

Gain insight into how listening to site feedback and prioritizing engagement, training, and local patient understanding can drive smoother startups and stronger study outcomes.

Rethinking Oncology Trials With a Statistical Methodology That Puts Patients First

New statistical frameworks such as net treatment benefit offer a multidimensional approach to evaluating efficacy, safety, and patient-centered outcomes in oncology trials.

Scaling eSource-Enabled Clinical Trials: Hospital Perspectives

The challenges, opportunities, and strategic outlook for oncology research centers.

Notable Discussions from SCOPE 2025: Aiming to Calculate, Accommodate, and Innovate for Enhanced Drug Development

This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, and eCOA.

Embracing Proactive Multi-Indication Development for Metabolic Therapies

A 2025 survey highlights growing momentum for multi-indication drug development, with opportunities in innovative trial design, targeted patient selection, and real-world evidence to speed label expansion.

What Does Racial Color-Blindness Mean for Clinical Trial Participation?

Research collaboration between Tufts and the Society for Clinical Research Sites explores the prevalence of this belief in healthcare.